Form 4: Ekso Bionics Holdings Director Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Scott G. Davis, a Director of Ekso Bionics Holdings, Inc., received 51,626 shares of common stock on October 2, 2026.

Summary

  • Grant/award: acquired 51,626 Common Stock on October 2, 2026; holds 239,760 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Scott G. Davis — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-10-02Grant/awardCommon Stock51,626——239,760

Key Dates

DateDescription
2026-10-02Grant/award (51,626 shares)

Keywords

insider transaction, Form 4, CHRN, ChronoScale Holdings Corp, neutral, Scott G. Davis

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.